Immune cell dysfunction and inflammation in end-stage renal disease

Nature Reviews Nephrology

Volumn 9, Issue 5, 2013, Pages 255-265

  Betjes, Michiel G H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 7; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; GRANULOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DYSREGULATION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOSURVEILLANCE; IN VITRO STUDY; INNATE IMMUNITY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MACROPHAGE; MEMORY CELL; MONOCYTE; NATURAL KILLER CELL; NEPHRITIS; NEUTROPHIL; OXIDATIVE STRESS; PHAGOCYTOSIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; UREMIA;

HUMANS; IMMUNE SYSTEM; INFLAMMATION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LEUKOCYTES; UREMIA;

EID: 84876975542     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2013.44     Document Type: Review

References (140)

1. Sarnak, M. J. & Jaber, B. L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 58, 1758-1764 (2000).
2. Verkade, M. A. et al. Peripheral blood dendritic cells and GM CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int. 66, 614-621 (2004).
3. Stewart, J. H et al. The pattern of excess cancer in dialysis and transplantation. Nephrol. Dial. Transplant. 24, 3225-3231 (2009).
4. Vaziri, N. D. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin. Nephrol. 24, 469-473 (2004).
5. Pecoits-Filho, R. et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am. J. Kidney Dis. 41, 1212-1218 (2003).
6. Locatelli, F. et al. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol. Dial. Transplant. 18, 1272-1280 (2003).
7. Kato, S. et al. Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 3, 1526-1533 (2008).
8. Bohlender, J. M., Franke, S., Stein, G. & Wolf, G. Advanced glycation end products and the kidney. Am. J. Physiol. Renal Physiol. 289, F645- F659 (2005).
9. Bierhaus, A. & Nawroth, P. P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 52, 2251-2263 (2009).
10. Meier, P., Golshayan, D., Blanc, E., Pascual, M. & Burnier, M. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J. Am. Soc. Nephrol. 20, 1368-1384 (2009).
11. Recio-Mayoral, A., Banerjee, D., Streather, C. & Kaski, J. C. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease - a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 216, 446-451 (2011).
12. Hansson, G. K. & Libby, P. The immune response in atherosclerosis: A double-edged sword. Nat. Rev. Immunol. 6, 508-519 (2006).
13. Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32, S112- S119 (1998).
14. Meier, P., Dayer, E., Blanc, E. & Wauters, J. P. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J. Am. Soc. Nephrol. 13, 204-212 (2002).
15. van Riemsdijk, I. C. et al. T cells activate the tumor necrosis factor-α system during hemodialysis, resulting in tachyphylaxis. Kidney Int. 59, 883-892 (2001).
16. Akar, H., Akar, G. C., Carrero, J. J., Stenvinkel, P. & Lindholm, B. Systemic consequences of poor oral health in chronic kidney disease patients. Clin. J. Am. Soc. Nephrol. 6, 218-226 (2011).
17. Betjes, M. G., Langerak A. W., van der Spek, A., de Wit, E. A. & Litjens, N. H. Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int. 80, 208-217 (2011).
18. Nockher, W. A. & Scherberich, J. E. Expanded CD14+CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect. Immun. 66, 2782-2790 (1998).
19. Betjes, M. G., Huisman, M., Weimar, W. & Litjens, N. H. Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease. Kidney Int. 74, 760-767 (2008).
20. Iwasaki, A. & Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science 327, 291-295 (2010).
21. Riganti, C., Massaia, M., Davey, M. S. & Eberl, M. Human γδ T cell responses in infection and immunotherapy: Common mechanisms, common mediators? Eur. J. Immunol. 42, 1668-1676 (2012).
22. Hausmann, M. & Rogler, G. Immune- nonimmune networks in intestinal inflammation. Curr. Drug Targets 9, 388-394 (2008).
23. Cooper, M. D. & Alder, M. N. The evolution of adaptive immune systems. Cell 124, 815-822 (2006).
24. Nace, G., Evankovich, J., Eid, R. & Tsung, A. Dendritic cells and damage-associated molecular patterns: Endogenous danger signals linking innate and adaptive immunity. J. Innate Immun. 4, 6-15 (2012).
25. McHeyzer-Williams, L. J. & McHeyzer Williams, M. G. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23, 487-513 (2005).
26. Sela, S. et al. Primed peripheral polymorphonuclear leukocyte: A culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J. Am. Soc. Nephrol. 16, 2431-2438 (2005).
27. Gollapudi, P., Yoon, J. W., Gollapudi, S., Pahl, M. V. & Vaziri, N. D. Leukocyte toll-like receptor expression in end-stage kidney disease. Am. J. Nephrol. 31, 247-254 (2010).
28. Yoon, J. W., Pahl, M. V. & Vaziri, N. D. Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int. 71, 167-172 (2007).
29. Mazor, R. et al. Tumor necrosis factor-α: A possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension. Hypertension 55, 353-362 (2010).
30. Roselaar, S. E. et al. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int. 48, 199-206 (1995).
31. Descamps-Latscha, B. & Witko-Sarsat, V. Importance of oxidatively modified proteins in chronic renal failure. Kidney Int. Suppl. 78, S108- S113 (2001).
32. Toure, F. et al. Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem. J. 416, 255-261 (2008).
33. Pindjakova, J. & Griffin, M. D. Defective neutrophil rolling and transmigration in acute uremia. Kidney Int. 80, 447-450 (2011).
34. Mahajan, S., Kalra, O. P., Asit, K. T., Ahuja, G. & Kalra, V. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Ren. Fail. 27, 357-360 (2005).
35. Anding, K., Gross, P., Rost, J. M., Allgaier, D. & Jacobs, E. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol. Dial. Transplant. 18, 2067-2073 (2003).
36. Cendoroglo, M. et al. Neutrophil apoptosis and dysfunction in uremia. J. Am. Soc. Nephrol. 10, 93-100 (1999).
37. Jaber, B. L., Perianayagam, M. C., Balakrishnan, V. S., King, A. J. & Pereira, B. J. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO 1, CD95)/Fas ligand system. J. Leukoc. Biol. 69, 1006-1012 (2001).
38. Glorieux, G., Vanholder, R. & Lameire, N. Uraemic retention and apoptosis: What is the balance for the inflammatory status in uraemia? Eur. J. Clin. Invest. 33, 631-634 (2003).
39. Majewska, E., Baj, Z., Sulowska, Z., Rysz, J. & Luciak, M. Effects of uraemia and haemodialysis on neutrophil apoptosis and expression of apoptosis-related proteins. Nephrol. Dial. Transplant. 18, 2582-2588 (2003).
40. Witko-Sarsat, V. et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N acetylcysteine treatment in dialysis patients. Kidney Int. 64, 82-91 (2003).
41. Cohen, G., Rudnicki, M., Walter, F., Niwa, T. & Horl, W. H. Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes. J. Am. Soc. Nephrol. 12, 1264-1271 (2001).
42. Horl, W. H. Neutrophil function and infections in uremia. Am. J. Kidney Dis. 33, xlv- xlviii (1999).
43. Chonchol, M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin. Dial. 19, 291-296 (2006).
44. Witko-Sarsat, V., Gausson, V. & Descamps Latscha, B. Are advanced oxidation protein products potential uremic toxins? Kidney Int. Suppl. 84, S11- S14 (2003).
45. Paulsson, J., Dadfar, E., Held, C., Jacobson, S. H. & Lundahl, J. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 192, 328-334 (2007).
46. Vlahu, C. A. et al. Damage of the endothelial glycocalyx in dialysis patients. J. Am. Soc. Nephrol. 23, 1900-1908 (2012).
47. Klein, J. B., McLeish, K. R. & Ward, R. A. Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst. Am. J. Kidney Dis. 33, 483-491 (1999).
48. Moretta, L. et al. Effector and regulatory events during natural killer- dendritic cell interactions. Immunol. Rev. 214, 219-228 (2006).
49. Lodoen, M. B. & Lanier, L. L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18, 391-398 (2006).
50. Griveas, I. et al. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis. Ren. Fail. 27, 279-282 (2005).
51. Charpentier, B. et al. Depressed polymorphonuclear leukocyte functions associated with normal cytotoxic functions of T and natural killer cells during chronic hemodialysis. Clin. Nephrol. 19, 288-294 (1983).
52. Gascon, A. et al. Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients. Am. J. Kidney Dis. 27, 373-379 (1996).
53. Zaoui, P. & Hakim, R. M. Natural killer cell function in hemodialysis-patients - effect of the dialysis membrane. Kidney Int. 43, 1298-1305 (1993).
54. Cala, S., Mazuran, R. & Kordic, D. Negative effect of uraemia and cuprophane haemodialysis on natural killer cells. Nephrol. Dial. Transplant. 5, 437-440 (1990).
55. Peraldi, M. N. et al. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J. Immunol. 182, 1696-705 (2009).
56. Vacher-Coponat, H. et al. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. Nephrol. Dial. Transplant. 23, 1406-1414 (2008).
57. Hutchinson, P., Chadban, S. J., Atkins, R. C. & Holdsworth, S. R. Laboratory assessment of immune function in renal transplant patients. Nephrol. Dial. Transplant. 18, 983-989 (2003).
58. Carroll, R. P. et al. Immune phenotype predicts risk for posttransplantation squamous cell carcinoma. J. Am. Soc. Nephrol. 21, 713-722 (2010).
59. Lim, W. H., Kireta, S., Leedham, E., Russ, G. R. & Coates, P. T. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int. 72, 1138-1148 (2007).
60. De Cal, M. et al. Oxidative stress and 'monocyte reprogramming' after kidney transplant: A longitudinal study. Blood Purif. 26, 105-110 (2008).
61. Satomura, A. et al. Significant elevations in serum mannose-binding lectin levels in patients with chronic renal failure. Nephron 92, 702-704 (2002).
62. Ando, M., Lundkvist, I., Bergstrom, J. & Lindholm, B. Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients. Kidney Int. 49, 773-780 (1996).
63. Ando, M., Gafvels, M., Bergstrom, J., Lindholm, B. & Lundkvist, I. Uremic serum enhances scavenger receptor expression and activity in the human monocytic cell line U937. Kidney Int. 51, 785-792 (1997).
64. Muniz-Junqueira, M. I., Braga Lopes, C., Magalhaes, C. A., Schleicher, C. C. & Veiga, J. P. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro inflammatory cytokines production in chronic renal failure patients. Life Sci. 77, 3141-3155 (2005).
65. Lewis, S. L. & Van Epps, D. E. Neutrophil and monocyte alterations in chronic dialysis patients. Am. J. Kidney Dis. 9, 381-395 (1987).
66. Chmielewski, M. et al. Expression of scavenger receptor CD36 in chronic renal failure patients. Artif. Organs 29, 608-614 (2005).
67. Ando, M., Shibuya, A., Tsuchiya, K., Akiba, T. & Nitta, K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 70, 358-362 (2006).
68. Ziegler-Heitbrock, L. The CD14+CD16+ blood monocytes: Their role in infection and inflammation. J. Leukoc. Biol. 81, 584-592 (2007).
69. Scherberich, J. E., Estner, H. & Segerer, W. Impact of different immunosuppressive regimens on antigen-presenting blood cells in kidney transplant patients. Kidney Blood Press. Res. 27, 177-180 (2004).
70. Zawada, A. M. et al. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118, e50- e61 (2011).
71. Heine, G. H. et al. CD14++CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int. 73, 622-629 (2008).
72. Rogacev, K. S. et al. CD14++CD16+ monocytes independently predict cardiovascular events: A cohort study of 951 patients referred for elective coronary angiography. J. Am. Coll. Cardiol. 60, 1512-1520 (2012).
73. Rogacev, K. S. et al. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur. Heart J. 32, 84-92 (2011).
74. Pahl, M. V., Vaziri, N. D., Yuan, J. & Adler, S. G. Upregulation of monocyte/macrophage HGFIN (Gpnmb/osteoactivin) expression in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 5, 56-61 (2010).
75. Girndt, M. et al. Production of interleukin 6, tumor necrosis factor α and interleukin 10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int. 47, 559-565 (1995).
76. Girndt, M. et al. Anti-inflammatory interleukin 10 genotype protects dialysis patients from cardiovascular events. Kidney Int. 62, 949-955 (2002).
77. Girndt, M., Sester, U., Kaul, H. & Kohler, H. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J. Am. Soc. Nephrol. 9, 1689-1696 (1998).
78. Stenvinkel, P. et al. IL 10, IL 6, and TNF-α: Central factors in the altered cytokine network of uremia - the good, the bad, and the ugly. Kidney Int. 67, 1216-1233 (2005).
79. Shi, C. et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 34, 590-601 (2011).
80. O'Donnell, V. B. & Murphy, R. C. New families of bioactive oxidized phospholipids generated by immune cells: Identification and signaling actions. Blood 120, 1985-1992 (2012).
81. Watson, A. D. et al. Structural identification of a novel proinflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J. Biol. Chem. 274, 24787-24798 (1999).
82. Betjes, M. G. et al. Immuno-effector characteristics of peritoneal cells during CAPD treatment: A longitudinal study. Kidney Int. 43, 641-648 (1993).
83. Betjes, M. G. et al. Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. Nephrol. Dial. Transplant. 9, 684-692 (1994).
84. Zemel, D. et al. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Perit. Dial. Int. 15, 134-141 (1995).
85. Ulrich, C., Heine, G. H., Gerhart, M. K., Kohler, H. & Girndt, M. Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am. J. Transplant. 8, 103-110 (2008).
86. Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661 (2010).
87. Steinman, R. M. & Idoyaga, J. Features of the dendritic cell lineage. Immunol. Rev. 234, 5-17 (2010).
88. Mettang, T. et al. Epidermal Langerhans cells in uremic patients on hemodialysis or continuous ambulatory peritoneal dialysis. Nephron 65, 278-283 (1993).
89. Verkade, M. A. et al. Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. Nephrol. Dial. Transplant. 22, 128-138 (2007).
90. Verkade M. A., van Druningen, C. J., Op de Hoek, C. T., Weimar, W. & Betjes, M. G. Decreased antigen-specific T cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis. Clin. Exp. Med. 7, 65-71 (2007).
91. Meuer, S. C., Hauer, M., Kurz, P., Meyer zum Buschenfelde, K. H. & Kohler, H. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J. Clin. Invest. 80, 743-749 (1987).
92. Lim, W. H., Kireta, S., Thomson, A. W., Russ, G. R. & Coates, P. T. Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation 81, 160-168 (2006).
93. Hesselink, D. A. et al. The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Nephrol. Dial. Transplant. 20, 1868-1873 (2005).
94. Agrawal, S., Gollapudi, P., Elahimehr, R., Pahl, M. V. & Vaziri, N. D. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol. Dial. Transplant. 25, 737-746 (2010).
95. Lim, W. H., Kireta, S., Russ, G. R. & Coates, P. T. Uremia impairs blood dendritic cell function in hemodialysis patients. Kidney Int. 71, 1122-1131 (2007).
96. Betjes, M. G. et al. Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis. Clin. Exp. Immunol. 94, 377-384 (1993).
97. Girndt, M., Pietsch, M. & Kohler, H. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am. J. Kidney Dis. 26, 454-460 (1995).
98. Dobler, C. C., McDonald, S. P. & Marks, G. B. Risk of tuberculosis in dialysis patients: A nationwide cohort study. PLoS ONE 6, e29563 (2011).
99. Vajdic, C. M. et al. Cancer incidence before and after kidney transplantation. JAMA 296, 2823-2831 (2006).
100. Womer, K. L. et al. Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients. Transplantation 89, 115-123 (2010).
101. Descamps-Latscha, B. & Chatenoud, L. T cells and B cells in chronic renal failure. Semin. Nephrol. 16, 183-191 (1996).
102. Litjens N. H., van Druningen, C. J. & Betjes, M. G. Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin. Immunol. 118, 83-91 (2006).
103. Yoon, J. W., Gollapudi, S., Pahl, M. V. & Vaziri, N. D. Naive and central memory T cell lymphopenia in end-stage renal disease. Kidney Int. 70, 371-376 (2006).
104. Brinkkoetter, P. T. et al. Altered CD46-mediated T cell co-stimulation in haemodialysis patients. Clin. Exp. Immunol. 139, 534-541 (2005).
105. Betjes, M. G., Meijers, R. W., de Wit, E. A., Weimar, W. & Litjens, N. H. Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection. Transplantation 94, 63-69 (2012).
106. Yadav, A. K. & Jha, V. CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis. Nephrol. Dial. Transplant. 26, 1689-1694 (2011).
107. Betjes, M. G., Meijers R. W., de Wit, L. E. & Litjens, N. H. A killer on the road: Circulating CD4+CD28null T cells as cardiovascular risk factor in ESRD patients. J. Nephrol. 25, 183-191 (2012).
108. Betjes, M. G., Weimar, W. & Litjens, N. H. CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD. J. Am. Soc. Nephrol. 20, 2661-2666 (2009).
109. Betjes M. G., de Wit, E. E., Weimar, W. & Litjens, N. H. Circulating pro-inflammatory CD4+CD28null T cells are independently associated with cardiovascular disease in ESRD patients. Nephrol. Dial. Transplant. 25, 3640-3646 (2010).
110. Meier, P., Dayer, E., Ronco, P. & Blanc, E. Dysregulation of IL 2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure. Clin. Nephrol. 63, 8-21 (2005).
111. Litjens, N. H., Huisman, M., van den Dorpel, M. & Betjes, M. G. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J. Am. Soc. Nephrol. 19, 1483-1490 (2008).
112. Litjens, N. H. et al. IL 2 producing memory CD4+ T lymphocytes are closely associated with the generation of IgG-secreting plasma cells. J. Immunol. 181, 3665-3673 (2008).
113. Kruger, S., Muller-Steinhardt, M., Kirchner, H. & Kreft, B. A 5 year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients. Am. J. Kidney Dis. 38, 1264-1270 (2001).
114. Tsouchnikas, I. et al. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination. Clin. Nephrol. 68, 228-234 (2007).
115. Charest, A. F., Grand'Maison, A., McDougall, J. & Goldstein, M. B. Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population. Am. J. Kidney Dis. 42, 1193-1199 (2003).
116. Calarota, S. A. et al. Kinetics of T lymphocyte subsets and post-transplant opportunistic infections in heart and kidney transplant recipients. Transplantation 93, 112-119 (2012).
117. Thibaudin, D., Alamartine, E., Mariat, C., Absi, L. & Berthoux, F. Long-term kinetic of T lymphocyte subsets in kidney-transplant recipients: Influence of anti T cell antibodies and association with post-transplant malignancies. Transplantation 80, 1514-1517 (2005).
118. George, J. Mechanisms of disease: The evolving role of regulatory T cells in atherosclerosis. Nat. Clin. Pract. Cardiovasc. Med. 5, 531-540 (2008).
119. Hendrikx, T, K. et al. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T cells. Nephrol. Dial. Transplant. 24, 1969-1978 (2009).
120. Berglund, D. et al. Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation. Transpl. Immunol. 26, 27-33 (2012).
121. Pahl, M. V. et al. Effect of end-stage renal disease on B lymphocyte subpopulations, IL 7, BAFF and BAFF receptor expression. Nephrol. Dial. Transplant. 25, 205-212 (2010).
122. Fernandez-Fresnedo, G. et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl 2. Nephrol. Dial. Transplant. 15, 502-510 (2000).
123. Bouts, A. H. et al. Immunoglobulins in chronic renal failure of childhood: Effects of dialysis modalities. Kidney Int. 58, 629-637 (2000).
124. Betjes, M. G., Litjens, N. H. & Zietse, R. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol. Dial. Transplant. 22, 3298-3303 (2007).
125. Beaman, M., Michael, J., MacLennan, I. C. & Adu, D. T cell independent and T cell dependent antibody responses in patients with chronic renal failure. Nephrol. Dial. Transplant. 4, 216-221 (1989).
126. Chen, J. et al. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int. 79, 288-299 (2011).
127. Vesosky, B., Flaherty, D. K., Rottinghaus, E. K., Beamer, G. L. & Turner, J. Age dependent increase in early resistance of mice to Mycobacterium tuberculosis is associated with an increase in CD8 T cells that are capable of antigen independent IFN-γ production. Exp. Gerontol. 41, 1185-1194 (2006).
128. Sportes, C. et al. Administration of rhIL 7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J. Exp. Med. 205, 1701-1714 (2008).
129. Raskova, J., Czerwinski, D. K., Shea, S. M. & Raska, K. Jr. Cellular immunity and lymphocyte populations in developing uremia in the rat. J. Exp. Pathol. 2, 229-245 (1986).
130. McKay, D. & Jameson, J. Kidney transplantation and the ageing immune system. Nat. Rev. Nephrol. 8, 700-708 (2012).
131. Merino, A. et al. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J. Immunol. 186, 1809-1815 (2011).
132. Franceschi, C. et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92-105 (2007).
133. Meijers, R. W. et al. Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients. Immun. Ageing 9, 19 (2012).
134. Trzonkowski, P. et al. Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T cells. Mech. Ageing Dev. 131, 96-104 (2010).
135. Simmons, E. M. et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 79, 914-919 (2005).
136. Cho, R. H., Sieburg, H. B. & Muller-Sieburg, C. E. A new mechanism for the aging of hematopoietic stem cells: Aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111, 5553-5561 (2008).
137. Muller-Sieburg, C. E., Sieburg, H. B., Bernitz, J. M. & Cattarossi, G. Stem cell heterogeneity: Implications for aging and regenerative medicine. Blood 119, 3900-3907 (2012).
138. Roeder, I. et al. Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: A model-based approach. Blood 112, 4874-4883 (2008).
139. Chambers, S. M. et al. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. 5, e201 (2007).
140. Zawada, A. M. et al. SuperTAG methylation-specific digital karyotyping (SMSDK) reveals uremia induced epigenetic dysregulation of atherosclerosis- related genes. Circ. Cardiovasc. Genet. 5, 611-620 (2012).